Analyst consensus rating
Boston Scientific Analyst Rating: Buy
BSX is rated Buy by 29 analysts with a $62.69 target. As of 2026-08-19.
Direct answer
Boston Scientific's consensus rating is Buy.
29 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $62.69.
Forecast evidence checked August 19, 2026.
Get free Boston Scientific email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $52.34
- Average price target
- $62.69
- High price target
- $94.00
- Low price target
- $44.00
- Low target gap
- -15.9%
- Target upside
- +19.8%
- High target gap
- +79.6%
- Target range width
- 95.5%
- Consensus rating
- Buy
- Analysts
- 29
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Boston Scientific?
Boston Scientific has a verified Buy consensus. The same dataset has an average price target of $62.69.
How far are Boston Scientific's low and high targets from the recorded price?
The low target implies -15.9%, while the high target implies +79.6%.
How many analysts are included in Boston Scientific's consensus?
The verified consensus includes 29 analysts.
How is Boston Scientific's target upside or downside calculated?
The average target of $62.69 is divided by the recorded price of $52.34, then one is subtracted to produce +19.8%. This does not guarantee a future return.
When was Boston Scientific's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.